Not provided
Not provided
Not provided
Not provided
Not provided
failed to included during covid pandemic
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this monocentric, prospective and descriptive trial we want to evaluate the long-term consequences for patients treated for Covid-19. Covid patients who were hospitalized for min. 5 days either in a Covid-19 department or in intensive care unit will be followed-up for 8 weeks after hospital discharge. This is done via an innovative electronic platform in the home environment (UZA@home). On the one hand the quality of life, rehabilitation and reintegration of the patient will be evaluated and on the other hand the patient will be screened for various psychosocial aspects such as anxiety, depression and post-traumatic stress syndrome.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 25 post ICU-patients | Diagnostic Test | patients who were hospitalized in an intensive care unit | ||
| 25 post non-ICU patients | Other | patients who were not hospitalized in an intensive care unit |
| Measure | Description | Time Frame |
|---|---|---|
| Health related Quality of life (general well-being) questionnaire | Evaluation of Quality of Life after hospitalization due to COVID-19 infection using the EQ-5D-5L questionnaire | in the first 7 days after hospital discharge |
| Health related Quality of life (general well-being) questionnaire | Evaluation of Quality of Life after hospitalization due to COVID-19 infection using the EQ-5D-5L questionnaire | 4 weeks after hospital discharge |
| Health related Quality of life (general well-being) questionnaire | Evaluation of Quality of Life after hospitalization due to COVID-19 infection using the EQ-5D-5L questionnaire | 8 weeks after hospital discharge |
| Measure | Description | Time Frame |
|---|---|---|
| Revalidation & Reintegration | Evaluation of revalidation of the patient after hospitalization (daily functioning and mobilization via a daily diary and objective measurements by means of remote monitoring techniques (saturation measurement, activity tracker, sleep monitor)). | daily, up to 8 weeks after hospital discharge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
We want to follow up 50 patients from hospital discharge, where we want to distinguish 2 groups:
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Antwerp University Hospital | Edegem | Antwerpen | 2650 | Belgium |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| Depression and/or anxiety |
Evaluation of depression and anxiety of the patient after hospitalization via the HADS (Hospital Anxiety and Depression Scale) questionnaire |
| 3 times after hospital discharge: first at week 0, second time at week 4, third time 8 weeks after discharge |
| Post traumatic stress syndrome | Evaluation of post traumatic stress syndrome of the patient after hospitalization via the PTSS questionnaire (of Erik De Soir) | 8 weeks after hospital discharge |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |